|
US7083983B2
(en)
|
1996-07-05 |
2006-08-01 |
Cancer Research Campaign Technology Limited |
Inhibitors of the interaction between P53 and MDM2
|
|
GB9708092D0
(en)
*
|
1997-04-22 |
1997-06-11 |
Univ Dundee |
Materials and methods relating to inhibiting the interaction of p53 and mdm2
|
|
WO1998051707A1
(fr)
*
|
1997-05-15 |
1998-11-19 |
Kyowa Hakko Kogyo Co., Ltd. |
Peptides a structures cycliques et a effet restaurateur d'activite de la proteine p53 sur les mutants de ladite proteine
|
|
US6238921B1
(en)
*
|
1998-03-26 |
2001-05-29 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of human mdm2 expression
|
|
EP0947494A1
(en)
*
|
1998-03-30 |
1999-10-06 |
F. Hoffmann-La Roche Ag |
Derivatives of phenoxy acetic acid and phenoxymethyltetrazole having antitumor activity
|
|
AU4052399A
(en)
*
|
1998-05-26 |
1999-12-13 |
Institute Of Molecular And Cell Biology |
Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
|
|
GB9819860D0
(en)
|
1998-09-12 |
1998-11-04 |
Zeneca Ltd |
Chemical compounds
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
US20040038902A1
(en)
|
2000-04-05 |
2004-02-26 |
Pincus Matthew R. |
Peptides selectively lethal to malignant and transformed mammalian cells
|
|
CA2514374A1
(en)
|
2003-02-13 |
2004-09-02 |
Government Of The United States Of America, As Represented By The Secret Ary, Department Of Health And Human Services |
Deazaflavin compounds and methods of use thereof
|
|
EP1997828B1
(en)
|
2003-11-05 |
2017-10-04 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides from BCL-2 and uses thereof
|
|
WO2005097820A1
(en)
*
|
2004-04-06 |
2005-10-20 |
Korea Research Institute Of Bioscience And Biotechnology |
Peptides for inhibiting mdm2 function
|
|
DE602004024831D1
(de)
*
|
2004-04-22 |
2010-02-04 |
Ortho Mcneil Pharm Inc |
Hdm2-inhibitorkomplexe und verwendungen davon
|
|
EP2952522B1
(en)
|
2007-01-31 |
2019-10-30 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
AU2008232709C1
(en)
|
2007-03-28 |
2015-01-15 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
WO2010083347A2
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
SG176783A1
(en)
*
|
2009-06-16 |
2012-01-30 |
Univ Tokai |
Anti-gram-negative bacteria agent
|
|
WO2011005219A1
(en)
*
|
2009-07-07 |
2011-01-13 |
Agency For Science, Technology And Research |
Novel mdm2 binding peptides and uses thereof
|
|
WO2011023677A1
(en)
|
2009-08-26 |
2011-03-03 |
Novartis Ag |
Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
|
|
US20130072439A1
(en)
|
2009-09-22 |
2013-03-21 |
Huw M. Nash |
Peptidomimetic macrocycles
|
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
|
CU24130B1
(es)
|
2009-12-22 |
2015-09-29 |
Novartis Ag |
Isoquinolinonas y quinazolinonas sustituidas
|
|
KR20170058446A
(ko)
|
2010-08-13 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
EP2721007B1
(en)
|
2011-06-20 |
2015-04-29 |
Novartis AG |
Cyclohexyl isoquinolinone compounds
|
|
WO2012175520A1
(en)
|
2011-06-20 |
2012-12-27 |
Novartis Ag |
Hydroxy substituted isoquinolinone derivatives
|
|
AR088392A1
(es)
|
2011-10-18 |
2014-05-28 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos
|
|
MX351012B
(es)
*
|
2011-11-09 |
2017-09-28 |
Merz Pharma Gmbh & Co Kgaa |
Neurotoxinas que exhiben actividad biologica acortada.
|
|
US9408885B2
(en)
*
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
CA2862038C
(en)
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
EP2855483B1
(en)
|
2012-05-24 |
2017-10-25 |
Novartis AG |
Pyrrolopyrrolidinone compounds
|
|
BR112015009470A2
(pt)
|
2012-11-01 |
2019-12-17 |
Aileron Therapeutics Inc |
aminoácidos dissubstituídos e seus métodos de preparação e uso
|
|
WO2014115080A1
(en)
|
2013-01-22 |
2014-07-31 |
Novartis Ag |
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
|
|
US9403827B2
(en)
|
2013-01-22 |
2016-08-02 |
Novartis Ag |
Substituted purinone compounds
|
|
MX2015016344A
(es)
|
2013-05-27 |
2016-03-01 |
Novartis Ag |
Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
|
|
US9714249B2
(en)
|
2013-05-28 |
2017-07-25 |
Novartis Ag |
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
|
|
CA2912986A1
(en)
|
2013-05-28 |
2014-12-04 |
Novartis Ag |
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
|
|
US9550796B2
(en)
|
2013-11-21 |
2017-01-24 |
Novartis Ag |
Pyrrolopyrrolone derivatives and their use as BET inhibitors
|
|
WO2016049359A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
SG11201702175YA
(en)
|
2014-09-24 |
2017-04-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof
|
|
US10253067B2
(en)
|
2015-03-20 |
2019-04-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
JP2018528217A
(ja)
|
2015-09-10 |
2018-09-27 |
エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子
|
|
EP3458101B1
(en)
|
2016-05-20 |
2020-12-30 |
H. Hoffnabb-La Roche Ag |
Protac antibody conjugates and methods of use
|
|
US20200354413A1
(en)
|
2017-12-15 |
2020-11-12 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
|
WO2020023502A1
(en)
|
2018-07-23 |
2020-01-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
CN109206474A
(zh)
*
|
2018-11-27 |
2019-01-15 |
青岛海洋生物医药研究院 |
一种线性肽合成方法
|
|
US20220153868A1
(en)
*
|
2019-02-20 |
2022-05-19 |
Oncolyze, Inc |
Hdm2 antibody for use in treating cancer
|
|
CN112266407B
(zh)
*
|
2020-09-28 |
2023-05-12 |
宁夏医科大学总医院 |
特异结合p53蛋白的七肽、编码基因、制备方法及用途
|
|
EP4312749A4
(en)
*
|
2021-03-31 |
2025-07-09 |
Zeteo Tech Inc |
DIAGNOSIS OF RESPIRATORY DISEASES BY CAPTURE OF AEROSOLIZED BIOMATERIAL PARTICLES USING FIXED BED SYSTEMS AND METHODS
|
|
WO2023056069A1
(en)
|
2021-09-30 |
2023-04-06 |
Angiex, Inc. |
Degrader-antibody conjugates and methods of using same
|
|
WO2024240858A1
(en)
|
2023-05-23 |
2024-11-28 |
Valerio Therapeutics |
Protac molecules directed against dna damage repair system and uses thereof
|